Background and Reference
Disclosure is subsequent to earlier filing dated April 9, 2026, regarding effective date of amalgamation scheme. The scheme was approved and sanctioned by the National Company Law Tribunal, Ahmedabad Bench vide its Order dated March 16, 2026.
Board Resolution Details
The Board of Directors of Lyka Labs Limited passed a circular resolution on June 12, 2026, approving allotment of equity shares to shareholders of Lyka Exports Limited ("Transferor Company").
Share Allotment Details
- Number of shares allotted: 4,62,711 (Four Lakh Sixty Two Thousand Seven Hundred and Eleven) Equity Shares
- Face value: ₹10 per share (Rupees Ten Only)
- Allottees: Shareholders holding shares of Lyka Exports Limited as on Record Date June 4, 2026
- Allotment ratio: 23 fully paid-up equity shares of Lyka Labs (face value ₹10) for every 100 fully paid-up equity shares (face value ₹10) held in Lyka Exports Limited
Capital Structure Impact
Post-allotment paid-up equity share capital increased to ₹36,15,27,110 (Rupees Thirty Six Crores Fifteen Lakhs Twenty Seven Thousand One Hundred and Ten Only).
The capital is divided into 3,61,52,711 (Three Crore Sixty One Lakhs Fifty Two Thousand Seven Hundred and Eleven) fully paid-up equity shares of face value ₹10 each.
Share Characteristics and Listing
The newly allotted equity shares will rank pari-passu with existing equity shares of the company. The shares are proposed to be listed and traded on BSE Limited and the National Stock Exchange of India Limited.
Additional Information
The information will also be available on the company website at www.lykalabs.com.